408 related articles for article (PubMed ID: 19641362)
1. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
Wang CJ; Huang SW; Chang CH
Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
[TBL] [Abstract][Full Text] [Related]
2. Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.
Mokhtari G; Shakiba M; Ghodsi S; Farzan A; Heidari Nejad S; Esmaeili S
Urol Int; 2011; 87(1):19-22. PubMed ID: 21597261
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for alpha1-blockers in treating double-J stent-related symptoms?
Deliveliotis C; Chrisofos M; Gougousis E; Papatsoris A; Dellis A; Varkarakis IM
Urology; 2006 Jan; 67(1):35-9. PubMed ID: 16413328
[TBL] [Abstract][Full Text] [Related]
4. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
6. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
7. Effects of specific alpha-1A/1D blocker on lower urinary tract symptoms due to double-J stent: a prospectively randomized study.
Wang CJ; Huang SW; Chang CH
Urol Res; 2009 Jun; 37(3):147-52. PubMed ID: 19277623
[TBL] [Abstract][Full Text] [Related]
8. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.
Al-Ansari A; Al-Naimi A; Alobaidy A; Assadiq K; Azmi MD; Shokeir AA
Urology; 2010 Jan; 75(1):4-7. PubMed ID: 20109697
[TBL] [Abstract][Full Text] [Related]
10. Stent positioning after ureteroscopy for urinary calculi: the question is still open.
Damiano R; Autorino R; Esposito C; Cantiello F; Sacco R; de Sio M; D'Armiento M
Eur Urol; 2004 Sep; 46(3):381-7; discussion 387-8. PubMed ID: 15306112
[TBL] [Abstract][Full Text] [Related]
11. Intermittent tamsulosin therapy in men with lower urinary tract symptoms.
Yanardag H; Goktas S; Kibar Y; Kilic S; Erduran D
J Urol; 2005 Jan; 173(1):155-7. PubMed ID: 15592062
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction.
Gupta M; Patel T; Xavier K; Maruffo F; Lehman D; Walsh R; Landman J
J Urol; 2010 Feb; 183(2):598-602. PubMed ID: 20018320
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tamsulosin hydrochloride in relieving "double-J ureteral stent-related morbidity": a randomized placebo controlled clinical study.
Singh I; Tripathy S; Agrawal V
Int Urol Nephrol; 2014 Dec; 46(12):2279-83. PubMed ID: 25201459
[TBL] [Abstract][Full Text] [Related]
15. Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study.
Damiano R; Autorino R; De Sio M; Giacobbe A; Palumbo IM; D'Armiento M
J Endourol; 2008 Apr; 22(4):651-6. PubMed ID: 18338955
[TBL] [Abstract][Full Text] [Related]
16. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
Zhang K; Yu W; Jin J; Ye H; Wang X; Zhang N; Yang Y; Zhong C; Wan B
Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
[TBL] [Abstract][Full Text] [Related]
17. Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial.
Tehranchi A; Rezaei Y; Khalkhali H; Rezaei M
Int Braz J Urol; 2013; 39(6):832-40. PubMed ID: 24456787
[TBL] [Abstract][Full Text] [Related]
18. Comparison of efficacy and tolerance of short-duration open-ended ureteral catheter drainage and tamsulosin administration to indwelling double J stents following ureteroscopic removal of stones.
Chauhan VS; Bansal R; Ahuja M
Hong Kong Med J; 2015 Apr; 21(2):124-30. PubMed ID: 25756274
[TBL] [Abstract][Full Text] [Related]
19. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study.
Beddingfield R; Pedro RN; Hinck B; Kreidberg C; Feia K; Monga M
J Urol; 2009 Jan; 181(1):170-6. PubMed ID: 19013590
[TBL] [Abstract][Full Text] [Related]
20. Ureteral stents: morbidity and impact on quality of life.
Leibovici D; Cooper A; Lindner A; Ostrowsky R; Kleinmann J; Velikanov S; Cipele H; Goren E; Siegel YI
Isr Med Assoc J; 2005 Aug; 7(8):491-4. PubMed ID: 16106772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
